Evolutionary double-bind treatment using radiotherapy and NK cell-based immunotherapy in prostate cancer. Luddy KA, West J, Robertson-Tessi M, Desai B, et al. Int J Radiat Oncol Biol Phys 2025 Sep 23:S0360-3016(25)06293.

Read + Share

Amedeo Smart

Independent Medical Education

Luddy KA, West J, Robertson-Tessi M, Desai B, et al. Evolutionary double-bind treatment using radiotherapy and NK cell-based immunotherapy in prostate cancer. Int J Radiat Oncol Biol Phys 2025 Sep 23:S0360-3016(25)06293.
PMID: 40998270